| Range: | 1.0E-6-1.0E-4 | Vol Avg: | 0 | Last Div: | 0 | Changes: | 0 |
| Beta: | 0 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Thu Dec 13 2012 | Empoloyees: | |||
| CUSIP: | 070249107 | CIK: | 0001495028 | ISIN: | US0702491079 | Country: | US |
| CEO: | Mr. Dennis R. Alexander | Website: | https://www.cantechpharma.com | ||||
BSSP 0.00 Stock Price Reve Technologies, Inc.
Reve Technologies, Inc., a drug development company, provides advanced therapeutics for the treatment of cancer. It offers irreversible pepsin fraction (IPF), a therapeutic platform technology that is used to facilitate a range of applications. The company's solution is also used for the treatment of autoimmune diseases, such as cirrhosis and Hepatitis C. The company was founded in 2010 and is based in San Clemente, California.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow